And finally – the NSF for Long Term Conditions
March 31, 2005The National Service Framework for Long Term Conditions has been launched by the government, which has pledged that it will …
Renamed agency responds to pharma’s strategic aims
March 31, 2005Medical Communications
Healthcare communications agency Brader Perryman has changed its name to Seven Stones, a move designed to reflect its diversity of …
Greater openness required by new European laws
March 31, 2005Pharmaceutical companies will be obliged to share safety data more openly from November with the adoption of new pan-European laws.The …
Europe unaffected by GSK’s manufacturing problems
March 31, 2005Sales and Marketing
Batches of GlaxoSmithKline's diabetes treatment Avandamet and depression treatment Paxil CR have been seized in the US due to continuing …
New drug applications to keep rising, European regulator says
March 31, 2005Sales and Marketing
The EMEA says it received 51 new drug applications in 2004, a figure which represents a significant rise over the …
Industry heads speak out against new European hurdle
March 31, 2005Sales and Marketing
Two leading pharmaceutical executives have criticised European regulators for demanding that new treatments be compared with existing drugs before they …
Stroke audit uncovers alarming variation in medication in UK
March 30, 2005An in-depth audit of services for stroke patients shows standards of care are generally improving – but progress is slow …
Finding the right NHS partner
March 23, 2005Pharma companies want to work with the NHS and the NHS wants to work with pharma companies. There is lots …
Serono hails progress towards MS gene map
March 22, 2005Sales and Marketing
Serono has announced it has reached a major milestone towards identifying the genes involved in multiple sclerosis.The company has identified …
Avastin partners boosted by lung cancer data
March 17, 2005Sales and Marketing
The share prices of Roche and Genentech have risen sharply on the back of news that Avastin extends the life …
BMS hepatitis drug set for approval
March 17, 2005Sales and Marketing
Bristol-Myers Squibb's Baraclude (entecavir) has been recommended for first-line treatment of chronic hepatitis B despite potential cancer risks.The US Food …
US doctors oppose black box warning for eczema drugs
March 17, 2005Sales and Marketing
US dermatologists have voiced their disapproval of new FDA restrictions on two eczema drugs because of potential cancer risks.The US …
MRC collaborates with Pfizer on enigmatic drug targets
March 16, 2005Sales and Marketing
Pfizer has entered into a collaboration with the UK's Medical Research Council commercial arm to develop new drug discovery techniques.Medical …
Telemedicine ‘disappearing from the NHS’
March 16, 2005Sales and Marketing
The hi-tech vision of doctors communicating with their patients via video, digital imaging and electronic data transmission is as far …
Confusion and apathy reign as GP commissioning nears
March 15, 2005Practice based commissioning, the latest radical reform which will re-shape the way the NHS treats patients is just days away …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
